DPLO News and Press, Diplomat Pharmacy Inc. From 12/09/19

Diplomat Pharmacy (NYSE: DPLO )  -32%  on discounted UNH bid. More news on: Diplomat Pharmacy, Inc., KalVista Pharmaceuticals, Inc., Taronis Technologies, Inc., Stocks on the move, Read more ...

Shares of Diplomat Pharmacy (NYSE: DPLO) are up 10.5% at 12:34 p.m. EST on no apparent news as investors continue to digest the value of a company with an uncertain future. Earlier this month, Diplomat Pharmacy said it lost a big account and was in danger of being foreclosed on by its cre...

Are These Penny Stocks Set To Head Higher This Week? One of the most important things to keep in mind with regards to penny stocks is that it’s possible to generate substantial returns within a short timespan. While that may be true, an investor still needs to conduct thorough researc...

Shares of Diplomat Pharmacy (NYSE: DPLO) bounced back 14% on Friday, just days after getting cut in half following the disclosure to investors that the company had lost a big account and was in danger of falling out of favor with its creditors. The volatility comes from the binary nature ...

Alnylam Pharmaceuticals (NASDAQ: ALNY ) initiated with Buy rating and $110 (21% upside) price target at BofA Merrill Lynch. More news on: Alnylam Pharmaceuticals, Inc., Arena Pharmaceuticals, Inc., National Vision Holdings, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Image source: The Motley Fool. Diplomat Pharmacy Inc   (NYSE: DPLO) Q3 2019 Earnings Call Nov 12, 2019 , 8:30 a.m. ET Operator Continue reading

The following slide deck was published by Diplomat Pharmacy, Inc. in conjunction with their 2019 Q3 earnings Read more ...

Diplomat Pharmacy, Inc. (DPLO) Q3 2019 Earnings Conference Call November 12, 2019 8:30 AM ET Company Participants Terri Anne Powers – Vice President-Investor Relations Brian Griffin – Chairman and Chief Executive Officer Dan Davison – Chief Financial Officer ...

Shares of Diplomat Pharmacy (NYSE: DPLO) are down 59% at 11:28 a.m. EST after the specialty pharmacy and pharmacy benefit manager released shocking news during its third-quarter earnings report: As of November 28, 2019, we will no longer participate in a significant group of specialty and r...

Solid Biosciences (NASDAQ: SLDB )  -71%  on another clinical hold on DMD gene therapy . More news on: Solid Biosciences Inc., Diplomat Pharmacy, Inc., Fluent, Inc., Stocks on the move, Read more ...